Actavis to enter Japan through new joint venture
This article was originally published in Scrip
Executive Summary
Actavisis going down the same route as competitor Teva Pharmaceutical Industriesto build up its presence in Japan's developing generics market. The Icelandic generics firm has signed a basic agreement with mid-sized Japanese company Aska Pharmaceutical to set up a joint venture next April 1st.